SABSWSAB Biotherapeutics, Inc.vs its industry peers
A metric-by-metric comparison of SAB Biotherapeutics, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SABSW본 종목 | $649945#9 | — | 0.0x#1 | — | -100.0%#8 | 138.9%#3 | — | 5.8%#1 | — | — | -78.8%#8 | — |
| LIMNW | $3M#3 | — | — | — | — | -187.8%#11 | — | — | -226.6%#1 | — | -65.3%#7 | — |
| AIM | $4M#2 | — | 1.8x#5 | 44.1x#6 | -48.2%#6 | 19.4%#8 | -13254.5%#8 | -656.8%#4 | — | — | -90.9%#11 | — |
| PHGE | $2M#4 | 0.0x#1 | — | — | — | -104.2%#10 | — | — | -250.4%#2 | — | -97.9%#12 | — |
| HUMAW | $2M#5 | — | 0.2x#3 | 0.9x#4 | — | 72.5%#5 | -5306.0%#6 | -351.3%#3 | — | — | -98.4%#13 | — |
| CEROW | $2M#6 | — | — | — | — | — | — | — | — | — | 152.1%#1 | 7.8%#2 |
| VIVS | $1M#7 | — | — | 9.9x#5 | -9.0%#4 | -456.4%#14 | -8768.7%#7 | — | — | — | -80.3%#9 | — |
| SCLXW | $1M#8 | — | — | 0.0x#1 | -46.5%#5 | -413.8%#13 | -1143.7%#2 | — | — | 4#1 | 137.2%#2 | 848.2%#1 |
| JSPRW | $305165#10 | — | 0.1x#2 | — | — | 100.0%#4 | — | -0.0%#2 | — | — | -89.1%#10 | — |
| SRZNW | $221758#11 | — | — | 0.1x#2 | -67.4%#7 | -280.8%#12 | -1210.6%#3 | — | — | — | 6.7%#5 | — |
| TVGNW | $201000#12 | — | — | — | — | -91.4%#9 | — | — | — | — | 10.9%#4 | — |
| SLXNW | $196090#13 | 0.0x#2 | 0.7x#4 | — | — | 27.9%#7 | — | -4093.5%#5 | — | — | 22.8%#3 | — |
| ABPWW | $116152#14 | 0.0x#3 | — | 0.6x#3 | 50.0%#2 | 218.1%#1 | -4618.6%#4 | — | — | — | -45.6%#6 | — |
| ABPO | — | — | — | — | 50.0%#2 | 218.1%#1 | -4618.6%#4 | — | — | — | — | — |
| ADAPY | — | — | — | — | 195.3%#1 | 37.8%#6 | -38.6%#1 | — | — | — | — | — |
| AGMB | $506M#1 | — | — | — | — | — | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-08-05.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice